AboutContactTerms & Privacy
© 2026 Coverager
All Rights Reserved

DalCor Pharmaceuticals

Developer of precision treatments for cardiovascular disease.

Headquarters
Montréal, Quebec, Canada
Founded
2015
Operating Status
Active
Ownership Type
Links
Number of funding rounds 4
Number of investors 8
Total funding amount $233.85M
Date Amount Stage Investors

Clients Only Feature

Client? Sign in to access this feature.
Not a client? Learn more about Coverager Research.